{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:05:52Z","timestamp":1790514352766,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T00:00:00Z","timestamp":1591660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T00:00:00Z","timestamp":1591660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Valproic acid or valproate (VPA) is an anticonvulsive drug used for treatments of epilepsy, bipolar disorder, and migraine headaches. VPA is also an epigenetic modulator, inhibiting histone deacetylase, and it has been subjected to clinical study for cancer treatment. During the investigation of VPA on a metabolite profile in a fungus, we found that VPA has significant effects on the production of some fatty acids. Further exploration of VPA on fatty acid profiles of microorganisms, fungi, yeast, and bacteria, as well as representative gut microbiome, revealed that VPA could enhance or reduce the production of some fatty acids. VPA was found to induce the production of\n                    <jats:italic>trans<\/jats:italic>\n                    -9-elaidic acid, a fatty acid that was previously reported to have cellular effects in human macrophages. VPA could also inhibit the production of some polyketides produced by a model fungus. The present work suggests that the induction or inhibition of fatty acid biosynthesis by VPA (100\u2009\u00b5M) in gut microbiome could give effects to patients treated with VPA because high doses of VPA oral administration (up to 600\u2009mg to 900\u2009mg) are used by patients; the concentration of VPA in the human gut may reach a concentration of 100\u2009\u00b5M, which may give effects to gut microorganisms.\n                  <\/jats:p>","DOI":"10.1038\/s41598-020-66251-y","type":"journal-article","created":{"date-parts":[[2020,6,9]],"date-time":"2020-06-09T06:02:46Z","timestamp":1591682566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["An anticonvulsive drug, valproic acid (valproate), has effects on the biosynthesis of fatty acids and polyketides in microorganisms"],"prefix":"10.1038","volume":"10","author":[{"given":"Prapassorn","family":"Poolchanuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panida","family":"Unagul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanit","family":"Thongnest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suthep","family":"Wiyakrutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nattaya","family":"Ngamrojanavanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chulabhorn","family":"Mahidol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somsak","family":"Ruchirawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasat","family":"Kittakoop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,9]]},"reference":[{"key":"66251_CR1","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1002\/hep.1840020622","volume":"2","author":"JH Lewis","year":"1982","unstructured":"Lewis, J. H., Zimmerman, H. J., Garrett, C. T. & Rosenberg, E. Valproate-induced hepatic steatogenesis in rats. Hepatology 2, 870\u2013873 (1982).","journal-title":"Hepatology"},{"key":"66251_CR2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/0003-9861(83)90602-1","volume":"223","author":"C-M Becker","year":"1983","unstructured":"Becker, C.-M. & Harris, R. A. Influence of valproic acid on hepatic carbohydrate and lipid metabolism. Arch Biochem Biophys 223, 381\u2013392 (1983).","journal-title":"Arch Biochem Biophys"},{"key":"66251_CR3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1023\/A:1021918104127","volume":"17","author":"A Verrotti","year":"2002","unstructured":"Verrotti, A., Trotta, D., Morgese, G. & Chiarelli, F. Valproate-induced hyperammonemic encephalopathy. Metab Brain Dis 17, 367\u2013373 (2002).","journal-title":"Metab Brain Dis"},{"key":"66251_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s10545-008-0841-x","volume":"31","author":"MF Silva","year":"2008","unstructured":"Silva, M. F. et al. Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: a review. J. Inherit Metab Dis 31, 205\u2013216 (2008).","journal-title":"J. Inherit Metab Dis"},{"key":"66251_CR5","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.bcp.2009.10.011","volume":"79","author":"CC Aires","year":"2010","unstructured":"Aires, C. C. et al. Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis. Biochem Pharmacol 79, 792\u2013799 (2010).","journal-title":"Biochem Pharmacol"},{"key":"66251_CR6","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/S0140-6736(87)92902-3","volume":"1","author":"M Hjelm","year":"1987","unstructured":"Hjelm, M., Oberholzer, V., Seakins, J., Thomas, S. & Kay, J. D. Valproate inhibition of urea synthesis. Lancet 1, 923\u2013924 (1987).","journal-title":"Lancet"},{"key":"66251_CR7","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/S0140-6736(86)92889-8","volume":"2","author":"M Hjelm","year":"1986","unstructured":"Hjelm, M., Oberholzer, V., Seakins, J., Thomas, S. & Kay, J. D. Valproate-induced inhibition of urea synthesis and hyperammonaemia in healthy subjects. Lancet 2, 859 (1986).","journal-title":"Lancet"},{"key":"66251_CR8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1017\/S1461145711001714","volume":"16","author":"S Kataoka","year":"2013","unstructured":"Kataoka, S. et al. Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid. Int. J. Neuropsychopharmacol 16, 91\u2013103 (2013).","journal-title":"Int. J. Neuropsychopharmacol"},{"key":"66251_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-24202-8","volume":"8","author":"P Sgad\u00f2","year":"2018","unstructured":"Sgad\u00f2, P., Rosa-Salva, O., Versace, E. & Vallortigara, G. Embryonic exposure to valproic acid impairs social predispositions of newly-hatched chicks. Sci Rep 8, 5919 (2018).","journal-title":"Sci Rep"},{"key":"66251_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-39014-7","volume":"9","author":"L Sailer","year":"2019","unstructured":"Sailer, L., Duclot, F., Wang, Z. & Kabbaj, M. Consequences of prenatal exposure to valproic acid in the socially monogamous prairie voles. Sci Rep 9, 2453 (2019).","journal-title":"Sci Rep"},{"key":"66251_CR11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.phrs.2017.08.006","volume":"128","author":"U Mahmood","year":"2018","unstructured":"Mahmood, U. et al. Dendritic spine anomalies and PTEN alterations in a mouse model of VPA-induced autism spectrum disorder. Pharmacol Res. 128, 110\u2013121 (2018).","journal-title":"Pharmacol Res."},{"key":"66251_CR12","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.expneurol.2017.04.017","volume":"299","author":"C Nicolini","year":"2018","unstructured":"Nicolini, C. & Fahnestock, M. The valproic acid-induced rodent model of autism. Exp Neurol 299, 217\u2013227 (2018).","journal-title":"Exp Neurol"},{"key":"66251_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.bbr.2019.01.034","volume":"364","author":"M Fontes-Dutra","year":"2019","unstructured":"Fontes-Dutra, M. et al. Abnormal empathy-like pro-social behaviour in the valproic acid model of autism spectrum disorder. Behav Brain Res. 364, 11\u201318 (2019).","journal-title":"Behav Brain Res."},{"key":"66251_CR14","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.brainres.2018.12.011","volume":"1708","author":"R Hajisoltani","year":"2019","unstructured":"Hajisoltani, R. et al. Hyperexcitability of hippocampal CA1 pyramidal neurons in male offspring of a rat model of autism spectrum disorder (ASD) induced by prenatal exposure to valproic acid: A possible involvement of Ih channel current. Brain Res. 1708, 188\u2013199 (2019).","journal-title":"Brain Res."},{"key":"66251_CR15","doi-asserted-by":"publisher","first-page":"36734","DOI":"10.1074\/jbc.M101287200","volume":"276","author":"CJ Phiel","year":"2001","unstructured":"Phiel, C. J. et al. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J. Biol. Chem. 276, 36734\u201336741 (2001).","journal-title":"J. Biol. Chem."},{"key":"66251_CR16","doi-asserted-by":"publisher","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","volume":"20","author":"M Gottlicher","year":"2001","unstructured":"Gottlicher, M. et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 20, 6969\u20136978 (2001).","journal-title":"EMBO J"},{"key":"66251_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ejphar.2018.07.057","volume":"835","author":"H Heers","year":"2018","unstructured":"Heers, H., Stanislaw, J., Harrelson, J. & Lee, M. W. Valproic acid as an adjunctive therapeutic agent for the treatment of breast cancer. Eur. J. Pharmacol 835, 61\u201374 (2018).","journal-title":"Eur. J. Pharmacol"},{"key":"66251_CR18","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ejps.2018.05.026","volume":"121","author":"MM Patel","year":"2018","unstructured":"Patel, M. M. & Patel, B. M. Repurposing of sodium valproate in colon cancer associated with diabetes mellitus: Role of HDAC inhibition. Eur. J. Pharm. Sci. 121, 188\u2013199 (2018).","journal-title":"Eur. J. Pharm. Sci."},{"key":"66251_CR19","doi-asserted-by":"publisher","first-page":"e0176855","DOI":"10.1371\/journal.pone.0176855","volume":"12","author":"CL Killick-Cole","year":"2017","unstructured":"Killick-Cole, C. L. et al. Repurposing the anti-epileptic drug sodium valproate as an adjuvant treatment for diffuse intrinsic pontine glioma. PloS One 12, e0176855 (2017).","journal-title":"PloS One"},{"key":"66251_CR20","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1038\/ijo.2017.166","volume":"41","author":"J Choi","year":"2017","unstructured":"Choi, J. et al. Role of the histone deacetylase inhibitor valproic acid in high-fat diet-induced hypertension via inhibition of HDAC1\/angiotensin II axis. Int. J. Obes. 41, 1702\u20131709 (2017).","journal-title":"Int. J. Obes."},{"key":"66251_CR21","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/jcpt.12726","volume":"43","author":"B Crosby","year":"2018","unstructured":"Crosby, B. & Deas, C. M. Repurposing medications for use in treating HIV infection: A focus on valproic acid as a latency-reversing agent. J. Clin. Pharm. Ther. 43, 740\u2013745 (2018).","journal-title":"J. Clin. Pharm. Ther."},{"key":"66251_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/srep36013","volume":"6","author":"K Desfoss\u00e9s-Baron","year":"2016","unstructured":"Desfoss\u00e9s-Baron, K. et al. Valproate inhibits MAP kinase signalling and cell cycle progression in S. cerevisiae. Sci. Rep 6, 36013 (2016).","journal-title":"Sci. Rep"},{"key":"66251_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-15165-3","volume":"7","author":"JI Yu","year":"2017","unstructured":"Yu, J. I. et al. Valproic acid sensitizes hepatocellular carcinoma cells to proton therapy by suppressing NRF2 activation. Sci. Rep. 7, 14986 (2017).","journal-title":"Sci. Rep."},{"key":"66251_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-016-2957-y","volume":"16","author":"F Caponigro","year":"2016","unstructured":"Caponigro, F. et al. Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and\/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial. BMC Cancer 16, 918 (2016).","journal-title":"BMC Cancer"},{"key":"66251_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1097\/MOG.0000000000000139","volume":"31","author":"AB Shreiner","year":"2015","unstructured":"Shreiner, A. B., Kao, J. Y. & Young, V. B. The gut microbiome in health and in disease. Curr. Opin. Gastroenterol 31, 69\u201375 (2015).","journal-title":"Curr. Opin. Gastroenterol"},{"key":"66251_CR26","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1136\/gutjnl-2018-316723","volume":"67","author":"PD Cani","year":"2018","unstructured":"Cani, P. D. Human gut microbiome: hopes, threats and promises. Gut 67, 1716\u20131725 (2018).","journal-title":"Gut"},{"key":"66251_CR27","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/phar.1890","volume":"37","author":"SA Flowers","year":"2017","unstructured":"Flowers, S. A., Evans, S. J., Ward, K. M., McInnis, M. G. & Ellingrod, V. L. Interaction between atypical antipsychotics and the gut microbiome in a bipolar disease cohort. Pharmacotherapy 37, 261\u2013267 (2017).","journal-title":"Pharmacotherapy"},{"key":"66251_CR28","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1039\/b804701d","volume":"6","author":"RB Williams","year":"2008","unstructured":"Williams, R. B., Henrikson, J. C., Hoover, A. R., Lee, A. E. & Cichewicz, R. H. Epigenetic remodeling of the fungal secondary metabolome. Org. Biomol. Chem. 6, 1895\u20131897 (2008).","journal-title":"Org. Biomol. Chem."},{"key":"66251_CR29","doi-asserted-by":"publisher","first-page":"18329","DOI":"10.1039\/C4RA00274A","volume":"4","author":"KM VanderMolen","year":"2014","unstructured":"VanderMolen, K. M. et al. Epigenetic manipulation of a filamentous fungus by the proteasome-inhibitor bortezomib induces the production of an additional secondary metabolite. RSC Adv 4, 18329\u201318335 (2014).","journal-title":"RSC Adv"},{"key":"66251_CR30","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1039\/C8RA08209J","volume":"9","author":"Y Li","year":"2019","unstructured":"Li, Y., Zhang, F., Banakar, S. & Li, Z. Bortezomib-induced new bergamotene derivatives xylariterpenoids H\u2013K from sponge-derived fungus Pestalotiopsis maculans 16F-12. RSC Adv 9, 599\u2013608 (2019).","journal-title":"RSC Adv"},{"key":"66251_CR31","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1016\/j.bmc.2017.01.048","volume":"25","author":"JR Gubiani","year":"2017","unstructured":"Gubiani, J. R. et al. An epigenetic modifier induces production of (10\u2019S)-verruculide B, an inhibitor of protein tyrosine phosphatases by Phoma sp. nov. LG0217, a fungal endophyte of Parkinsonia microphylla. Bioorg. Med. Chem. 25, 1860\u20131866 (2017).","journal-title":"Bioorg. Med. Chem."},{"key":"66251_CR32","doi-asserted-by":"crossref","unstructured":"El-Hawary SS et al. Epigenetic modifiers induce bioactive phenolic metabolites in the marine-derived fungus Penicillium brevicompactum. Mar Drugs 16 (2018).","DOI":"10.3390\/md16080253"},{"key":"66251_CR33","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1021\/acs.jnatprod.6b00997","volume":"80","author":"G Li","year":"2017","unstructured":"Li, G. et al. Epigenetic modulation of endophytic Eupenicillium sp. LG41 by a histone deacetylase inhibitor for production of decalin-containing compounds. J. Nat. Prod. 80, 983\u2013988 (2017).","journal-title":"J. Nat. Prod."},{"key":"66251_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s13568-017-0343-z","volume":"7","author":"A Magotra","year":"2017","unstructured":"Magotra, A. et al. Epigenetic modifier induced enhancement of fumiquinazoline C production in Aspergillus fumigatus (GA-L7): an endophytic fungus from Grewia asiatica L. AMB Express 7, 43 (2017).","journal-title":"AMB Express"},{"key":"66251_CR35","doi-asserted-by":"publisher","first-page":"e1800485","DOI":"10.1002\/cbdv.201800485","volume":"16","author":"A Triastuti","year":"2019","unstructured":"Triastuti, A. et al. How histone deacetylase inhibitors alter the secondary metabolites of Botryosphaeria mamane, an endophytic fungus isolated from Bixa orellana. Chem Biodivers 16, e1800485 (2019).","journal-title":"Chem Biodivers"},{"key":"66251_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1155\/2014\/540292","volume":"2014","author":"C Zutz","year":"2014","unstructured":"Zutz, C. et al. Fungi treated with small chemicals exhibit increased antimicrobial activity against facultative bacterial and yeast pathogens. BioMed. Res. Int. 2014, 13 (2014).","journal-title":"BioMed. Res. Int."},{"key":"66251_CR37","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3389\/fmicb.2016.00510","volume":"7","author":"C Zutz","year":"2016","unstructured":"Zutz, C. et al. Valproic acid induces antimicrobial compound production in Doratomyces microspores. Front Microbiol 7, 510 (2016).","journal-title":"Front Microbiol"},{"key":"66251_CR38","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1097\/MIB.0000000000000454","volume":"21","author":"C Chehoud","year":"2015","unstructured":"Chehoud, C. et al. Fungal signature in the gut microbiota of pediatric patients with Inflammatory bowel disease. Inflamm Bowel Dis 21, 1948\u20131956 (2015).","journal-title":"Inflamm Bowel Dis"},{"key":"66251_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/srep14600","volume":"5","author":"M Mar Rodriguez","year":"2015","unstructured":"Mar Rodriguez, M. et al. Obesity changes the human gut mycobiome. Sci. Rep. 5, 14600 (2015).","journal-title":"Sci. Rep."},{"key":"66251_CR40","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/ismej.2013.33","volume":"7","author":"EC von Rosenvinge","year":"2013","unstructured":"von Rosenvinge, E. C. et al. Immune status, antibiotic medication and pH are associated with changes in the stomach fluid microbiota. ISME J 7, 1354\u20131366 (2013).","journal-title":"ISME J"},{"key":"66251_CR41","doi-asserted-by":"publisher","first-page":"e59474","DOI":"10.1371\/journal.pone.0059474","volume":"8","author":"N Gouba","year":"2013","unstructured":"Gouba, N., Raoult, D. & Drancourt, M. Plant and fungal diversity in gut microbiota as revealed by molecular and culture investigations. PloS One 8, e59474 (2013).","journal-title":"PloS One"},{"key":"66251_CR42","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/ismej.2008.76","volume":"2","author":"PD Scanlan","year":"2008","unstructured":"Scanlan, P. D. & Marchesi, J. R. Micro-eukaryotic diversity of the human distal gut microbiota: qualitative assessment using culture-dependent and -independent analysis of faeces. ISME J 2, 1183\u20131193 (2008).","journal-title":"ISME J"},{"key":"66251_CR43","doi-asserted-by":"publisher","first-page":"e66019","DOI":"10.1371\/journal.pone.0066019","volume":"8","author":"C Hoffmann","year":"2013","unstructured":"Hoffmann, C. et al. Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents. Plos One 8, e66019 (2013).","journal-title":"Plos One"},{"key":"66251_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-017-0373-4","volume":"5","author":"AK Nash","year":"2017","unstructured":"Nash, A. K. et al. The gut mycobiome of the Human Microbiome Project healthy cohort. Microbiome 5, 153 (2017).","journal-title":"Microbiome"},{"key":"66251_CR45","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1637\/11780-121117-Reg.1","volume":"62","author":"I Sokol","year":"2018","unstructured":"Sokol, I., Gawel, A. & Bobrek, K. The prevalence of yeast and characteristics of the isolates from the digestive tract of clinically healthy turkeys. Avian Dis 62, 286\u2013290 (2018).","journal-title":"Avian Dis"},{"key":"66251_CR46","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.fm.2014.03.020","volume":"42","author":"H Lucena-Padros","year":"2014","unstructured":"Lucena-Padros, H., Caballero-Guerrero, B., Maldonado-Barragan, A. & Ruiz-Barba, J. L. Microbial diversity and dynamics of Spanish-style green table-olive fermentations in large manufacturing companies through culture-dependent techniques. Food Microbiol 42, 154\u2013165 (2014).","journal-title":"Food Microbiol"},{"key":"66251_CR47","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1074\/jbc.M003305200","volume":"276","author":"A Gurvitz","year":"2001","unstructured":"Gurvitz, A., Hamilton, B., Ruis, H. & Hartig, A. Peroxisomal degradation of trans-unsaturated fatty acids in the yeast Saccharomyces cerevisiae. J. Biol. Chem. 276, 895\u2013903 (2001).","journal-title":"J. Biol. Chem."},{"key":"66251_CR48","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jbiosc.2016.07.006","volume":"123","author":"T Nakamura","year":"2017","unstructured":"Nakamura, T. et al. Trans 18-carbon monoenoic fatty acid has distinct effects from its isomeric cis fatty acid on lipotoxicity and gene expression in Saccharomyces cerevisiae. J. Biosci. Bioeng. 123, 33\u201338 (2017).","journal-title":"J. Biosci. Bioeng."},{"key":"66251_CR49","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/jcb.24633","volume":"115","author":"JR Zacherl","year":"2014","unstructured":"Zacherl, J. R. et al. Elaidate, an 18-carbon trans-monoenoic fatty acid, inhibits \u03b2-oxidation in human peripheral blood macrophages. J. Cell. Biochem. 115, 62\u201370 (2014).","journal-title":"J. Cell. Biochem."},{"key":"66251_CR50","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/jcb.25002","volume":"116","author":"JR Zacherl","year":"2015","unstructured":"Zacherl, J. R. et al. Elaidate, an 18-carbon trans-monoenoic fatty acid, but not physiological fatty acids increases intracellular Zn2+ in human macrophages. J. Cell Biochem. 116, 524\u2013532 (2015).","journal-title":"J. Cell Biochem."},{"key":"66251_CR51","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.fmrre.2005.04.009","volume":"29","author":"EE Vaughan","year":"2005","unstructured":"Vaughan, E. E., Heilig, H. G., Ben-Amor, K. & de Vos, W. M. Diversity, vitality and activities of intestinal lactic acid bacteria and bifidobacteria assessed by molecular approaches. FEMS Microbiol Rev 29, 477\u2013490 (2005).","journal-title":"FEMS Microbiol Rev"},{"key":"66251_CR52","doi-asserted-by":"publisher","first-page":"583850","DOI":"10.1155\/2013\/583850","volume":"2013","author":"PP Balgir","year":"2013","unstructured":"Balgir, P. P., Kaur, B., Kaur, T., Daroch, N. & Kaur, G. In vitro and in vivo survival and colonic adhesion of Pediococcus acidilactici MTCC5101 in human gut. Biomed Res. Int. 2013, 583850 (2013).","journal-title":"Biomed Res. Int."},{"key":"66251_CR53","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1039\/b603600g","volume":"24","author":"S Smith","year":"2007","unstructured":"Smith, S. & Tsai, S. C. The type I fatty acid and polyketide synthases: a tale of two megasynthases. Nat. Prod. Rep 24, 1041\u20131072 (2007).","journal-title":"Nat. Prod. Rep"},{"key":"66251_CR54","doi-asserted-by":"publisher","first-page":"7220","DOI":"10.1039\/c2ob25959a","volume":"10","author":"SP Senadeera","year":"2012","unstructured":"Senadeera, S. P., Wiyakrutta, S., Mahidol, C., Ruchirawat, S. & Kittakoop, P. A novel tricyclic polyketide and its biosynthetic precursor azaphilone derivatives from the endophytic fungus Dothideomycete sp. Org. Biomol. Chem. 10, 7220\u20137226 (2012).","journal-title":"Org. Biomol. Chem."},{"key":"66251_CR55","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.phytochem.2014.09.013","volume":"108","author":"RT Hewage","year":"2014","unstructured":"Hewage, R. T., Aree, T., Mahidol, C., Ruchirawat, S. & Kittakoop, P. One strain-many compounds (OSMAC) method for production of polyketides, azaphilones, and an isochromanone using the endophytic fungus Dothideomycete sp. Phytochemistry 108, 87\u201394 (2014).","journal-title":"Phytochemistry"},{"key":"66251_CR56","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1016\/j.bmc.2017.03.040","volume":"25","author":"K Wijesekera","year":"2017","unstructured":"Wijesekera, K., Mahidol, C., Ruchirawat, S. & Kittakoop, P. Metabolite diversification by cultivation of the endophytic fungus Dothideomycete sp. in halogen containing media: Cultivation of terrestrial fungus in seawater. Bioorg Med. Chem. 25, 2868\u20132877 (2017).","journal-title":"Bioorg Med. Chem."},{"key":"66251_CR57","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1016\/j.tetlet.2012.05.156","volume":"53","author":"AL Gerea","year":"2012","unstructured":"Gerea, A. L. et al. Secondary metabolites produced by fungi derived from a microbial mat encountered in an iron-rich natural spring. Tetrahedron Lett 53, 4202\u20134205 (2012).","journal-title":"Tetrahedron Lett"},{"key":"66251_CR58","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1021\/np100838j","volume":"74","author":"WC Tayone","year":"2011","unstructured":"Tayone, W. C. et al. Stereochemical investigations of isochromenones and isobenzofuranones isolated from Leptosphaeria sp. KTC 727. J. Nat. Prod. 74, 425\u2013429 (2011).","journal-title":"J. Nat. Prod."},{"key":"66251_CR59","doi-asserted-by":"crossref","unstructured":"Prompanya C et al. New polyketides and new benzoic acid derivatives from the marine sponge-associated fungus Neosartorya quadricincta KUFA 0081. Mar Drugs 14 (2016).","DOI":"10.3390\/md14070134"},{"key":"66251_CR60","doi-asserted-by":"publisher","first-page":"11168","DOI":"10.1021\/jf903499y","volume":"57","author":"A Evidente","year":"2009","unstructured":"Evidente, A. et al. Papyracillic acid, a phytotoxic 1,6-dioxaspiro[4,4]nonene produced by Ascochyta agropyrina Var. nana, a potential mycoherbicide for Elytrigia repens biocontrol. J. Agric Food Chem. 57, 11168\u201311173 (2009).","journal-title":"J. Agric Food Chem."},{"key":"66251_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.fbio.2013.07.003","volume":"4","author":"J Suburu","year":"2013","unstructured":"Suburu, J. et al. Fatty acid metabolism: Implications for diet, genetic variation, and disease. Food Biosci 4, 1\u201312 (2013).","journal-title":"Food Biosci"},{"key":"66251_CR62","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/s00213-018-5006-5","volume":"236","author":"S Cussotto","year":"2019","unstructured":"Cussotto, S. et al. Differential effects of psychotropic drugs on microbiome composition and gastrointestinal function. Psychopharmacology 236, 1671\u20131685 (2019).","journal-title":"Psychopharmacology"},{"key":"66251_CR63","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00213-019-5185-8","volume":"236","author":"S Cussotto","year":"2019","unstructured":"Cussotto, S., Clarke, G., Dinan, T. G. & Cryan, J. F. Psychotropics and the microbiome: a chamber of secrets. Psychopharmacology 236, 1411\u20131432 (2019).","journal-title":"Psychopharmacology"},{"key":"66251_CR64","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1515\/bot-2016-0111","volume":"60","author":"P Unagul","year":"2017","unstructured":"Unagul, P. et al. Isolation, fatty acid profiles and cryopreservation of marine thraustochytrids from mangrove habitats in Thailand. Botanica Marina 60, 363\u2013379 (2017).","journal-title":"Botanica Marina"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66251-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66251-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66251-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T07:01:23Z","timestamp":1670310083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-66251-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,9]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["66251"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-66251-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,9]]},"assertion":[{"value":"12 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9300"}}